From Transcriptome to Therapy: The ncRNA Revolution in Neurodevelopmental Disorders
Preprint
- 18 November 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD) and intellectual disability (ID), arise from disruptions of tightly orchestrated molecular programmes that govern neurogenesis, synaptogenesis and circuit maturation. Although large-scale genomic analyses have identified numerous susceptibility loci, DNA variation alone explains only a fraction of disease heritability, highlighting the pivotal contribution of post-transcriptional and epigenetic regulation. Among these regulatory layers, non-coding RNAs (ncRNAs)—encompassing microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), PIWI-interacting RNAs (piRNAs) and transfer-RNA-derived small RNAs (tsRNAs)—have emerged as key modulators of neural differentiation, synaptic plasticity and intercellular communication. Multi-omics studies reveal that ncRNAs fine-tune chromatin accessibility, transcriptional output and translation through complex competing-endogenous-RNA (ceRNA) and ribonucleoprotein networks. While miRNAs sculpt neurogenesis and circuit remodelling, lncRNAs and circRNAs integrate chromatin and transcriptional control with exquisite spatial and temporal precision. Newly characterized small RNAs such as tsRNAs and piRNAs extend this regulatory repertoire by linking translational reprogramming, epigenetic memory and even intergenerational inheritance. Advances in single-cell and spatial transcriptomics have further mapped ncRNA expression to discrete neuronal and glial populations, revealing cell-type-specific vulnerability signatures across cortical and subcortical regions. Clinically, circulating ncRNAs—particularly those encapsulated within plasma or extracellular vesicles—exhibit robust and disease-specific expression patterns, supporting their promise as non-invasive biomarkers for early diagnosis and patient stratification. In parallel, innovations in RNA interference, antisense oligonucleotides, CRISPR-based editing and exosome-mediated delivery are transforming ncRNAs from molecular indicators into therapeutic instruments capable of restoring transcriptional and epigenetic equilibrium. Together, these converging insights position ncRNAs as both mechanistic determinants and translational targets in neurodevelopmental pathology. The emerging ncRNA landscape redefines the molecular architecture of brain development, offering a unifying framework that links genome regulation, environmental responsiveness and neural plasticity. Decoding this multilayered RNA circuitry will be pivotal for the development of next-generation diagnostics and RNA-guided therapies for neurodevelopmental disorders.Keywords
All Related Versions
- Version 1, 2025-11-18, Preprints
- Published version: Brain Sciences, 16 (1), 17.
This publication has 85 references indexed in Scilit:
- Circ_0049472 downregulation relieves Amyloid-β-induced neuronal injury by modulating PDE4A expression via targeting miR-22-3p in Alzheimer’s diseaseMetabolic Brain Disease, 2025
- The miR-34a-5p Promotes Hippocampal Neuronal Ferroptosis in Epilepsy by Regulating SIRT1Neurochemical Research, 2025
- The MNK-SYNGAP1 axis in specific learning disorder: gene expression pattern and new perspectivesEuropean Journal of Pediatrics, 2025
- Diagnostic Value of Serum miR-499a-5p in Chinese Children with Autism Spectrum DisordersJournal of Molecular Neuroscience, 2025
- Identification of diagnostic and therapeutic biomarkers for attention‐deficit/hyperactivity disorderThe Kaohsiung Journal of Medical Sciences, 2025
- H19/miR‐484 axis serves as a candidate biomarker correlated with autism spectrum disorderInternational Journal of Developmental Neuroscience, 2025
- Assessment of Expression of lncRNAs in Autistic PatientsJournal of Molecular Neuroscience, 2024
- NEAT1 Promotes Valproic Acid-Induced Autism Spectrum Disorder by Recruiting YY1 to Regulate UBE3A TranscriptionMolecular Neurobiology, 2024
- Expression Patterns of miRNAs in Egyptian Children with ADHD: Clinical Study with Correlation AnalysisJournal of Molecular Neuroscience, 2024
- Association study of a single nucleotide polymorphism in brain cytoplasmic 200 long-noncoding RNA and psychiatric disordersMetabolic Brain Disease, 2020